These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38939760)

  • 1. Transdermal bisoprolol for prevention of postoperative atrial fibrillation: A systematic review and meta-analysis.
    Kim AG; Banga S; Ang QX; Atti L; Ghnaima H; AlAttal S; Banga P; Wilcox MD
    J Arrhythm; 2024 Jun; 40(3):434-439. PubMed ID: 38939760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisoprolol transdermal patch treatment for patients with atrial fibrillation after noncardiac surgery: A single-center retrospective study of 61 patients.
    Yasui T; Oka T; Shioyama W; Oboshi M; Fujita M
    SAGE Open Med; 2020; 8():2050312120907817. PubMed ID: 32128207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.
    Okamura H; Arakawa M; Miyagawa A; Adachi H
    Gen Thorac Cardiovasc Surg; 2019 Dec; 67(12):1007-1013. PubMed ID: 31049816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing postoperative atrial fibrillation after open-heart surgery using transdermal β
    Yamamoto K; Miwa S; Yamada T; Setozaki S; Hamuro M; Kurokawa S; Enomoto S
    J Cardiothorac Surg; 2023 Apr; 18(1):103. PubMed ID: 37024987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
    Iwano T; Toda H; Nakamura K; Shimizu K; Ejiri K; Naito Y; Mori H; Masuda T; Miyoshi T; Yoshida M; Hikasa Y; Morimatsu H; Ito H;
    J Cardiol; 2021 Nov; 78(5):349-354. PubMed ID: 34083113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
    Yamashita T; Ikeda T; Akita Y
    J Cardiol; 2019 May; 73(5):386-393. PubMed ID: 30591320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
    Imori Y; Takano H; Mase H; Matsuda J; Sangen H; Izumi Y; Tokita Y; Yamamoto T; Shimizu W
    BMC Cardiovasc Disord; 2019 Dec; 19(1):316. PubMed ID: 31888491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
    J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
    Nozaki A; Kobayashi T; Naruhashi K; Okugawa H; Horiuchi N; Nakanishi H; Kobayashi Y; Nakamura S
    Am J Emerg Med; 2021 Jan; 39():146-150. PubMed ID: 33039223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of Transdermal Patch of Bisoprolol for Paroxysmal Atrial Fibrillation after Open Heart Surgery].
    Yamamoto K; Yamada T; Hamuro M; Kawatou M; Enomoto S
    Kyobu Geka; 2017 Nov; 70(12):971-977. PubMed ID: 29104194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are beta-blockers effective for preventing post-coronary artery bypass grafting atrial fibrillation? Direct and network meta-analyses.
    Ji T; Feng C; Sun L; Ye X; Bai Y; Chen Q; Qin Y; Zhu J; Zhao X
    Ir J Med Sci; 2016 May; 185(2):503-11. PubMed ID: 27083460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Bisoprolol Transdermal Patches for Prevention of Perioperative Myocardial Injury in High-Risk Patients Undergoing Non-Cardiac Surgery　- Multicenter Randomized Controlled Study.
    Toda H; Nakamura K; Shimizu K; Ejiri K; Iwano T; Miyoshi T; Nakagawa K; Yoshida M; Watanabe A; Nishii N; Hikasa Y; Hayashi M; Morita H; Morimatsu H; Ito H;
    Circ J; 2020 Mar; 84(4):642-649. PubMed ID: 32092717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.
    Nyong J; Amit G; Adler AJ; Owolabi OO; Perel P; Prieto-Merino D; Lambiase P; Casas JP; Morillo CA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012088. PubMed ID: 27871122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraventricular tachyarrhythmias that responded dramatically to bisoprolol transdermal patches in two patients undergoing hemodialysis.
    Matsumoto T; Tamiya E; Yamamoto S; Kamiyama T; Takabe T; Kanoh T; Daida H
    Ann Noninvasive Electrocardiol; 2019 Nov; 24(6):e12660. PubMed ID: 31190422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia and Gout are Associated with the Risk of Atrial Fibrillation: An Updated Meta-Analysis.
    Deng Y; Li Q; Zhou F; Cai B; Guo J; Li G; Li L; Su X; Liu J; Chang D
    Rev Cardiovasc Med; 2022 May; 23(5):178. PubMed ID: 39077615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Effectiveness and Safety of Direct-Acting Oral Anticoagulants and Vitamin K Agonists in Patients With Atrial Fibrillation and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.
    Sinha T; Mayow AH; Abedin TT; Phoo CN; Shawl SH; Muhammad A; Kholoki S; Hirani S
    Cureus; 2024 Apr; 16(4):e57447. PubMed ID: 38699102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.